These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25407009)

  • 1. Design of an international multicentre RCT on group schema therapy for borderline personality disorder.
    Wetzelaer P; Farrell J; Evers SM; Jacob GA; Lee CW; Brand O; van Breukelen G; Fassbinder E; Fretwell H; Harper RP; Lavender A; Lockwood G; Malogiannis IA; Schweiger U; Startup H; Stevenson T; Zarbock G; Arntz A
    BMC Psychiatry; 2014 Nov; 14():319. PubMed ID: 25407009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.
    Fassbinder E; Assmann N; Schaich A; Heinecke K; Wagner T; Sipos V; Jauch-Chara K; Hüppe M; Arntz A; Schweiger U
    BMC Psychiatry; 2018 Oct; 18(1):341. PubMed ID: 30340474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder: A Randomized Clinical Trial.
    Arntz A; Jacob GA; Lee CW; Brand-de Wilde OM; Fassbinder E; Harper RP; Lavender A; Lockwood G; Malogiannis IA; Ruths FA; Schweiger U; Shaw IA; Zarbock G; Farrell JM
    JAMA Psychiatry; 2022 Apr; 79(4):287-299. PubMed ID: 35234828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of an RCT on cost-effectiveness of group schema therapy versus individual schema therapy for patients with Cluster-C personality disorder: the QUEST-CLC study protocol.
    Groot IZ; Venhuizen ASM; Bachrach N; Walhout S; de Moor B; Nikkels K; Dalmeijer S; Maarschalkerweerd M; van Aalderen JR; de Lange H; Wichers R; Hollander AP; Evers SMAA; Grasman RPPP; Arntz A
    BMC Psychiatry; 2022 Oct; 22(1):637. PubMed ID: 36209067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapy.
    Wibbelink CJM; Arntz A; Grasman RPPP; Sinnaeve R; Boog M; Bremer OMC; Dek ECP; Alkan SG; James C; Koppeschaar AM; Kramer L; Ploegmakers M; Schaling A; Smits FI; Kamphuis JH
    BMC Psychiatry; 2022 Feb; 22(1):89. PubMed ID: 35123450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of STEPPS in the treatment of patients with bipolar disorder and comorbid borderline personality features: a protocol for a randomized controlled trial.
    Riemann G; Weisscher N; Goossens PJ; Draijer N; Apenhorst-Hol M; Kupka RW
    BMC Psychiatry; 2014 Jun; 14():172. PubMed ID: 24912456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of iconic therapy for the reduction of borderline personality disorder symptoms among suicidal youth: study protocol for a randomised controlled trial.
    Hurtado-Santiago S; Guzmán-Parra J; Bersabé RM; Mayoral F
    BMC Psychiatry; 2018 Sep; 18(1):277. PubMed ID: 30176878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Day Hospital Mentalization-Based Treatment (MBT-DH) versus treatment as usual in the treatment of severe borderline personality disorder: protocol of a randomized controlled trial.
    Laurenssen EM; Westra D; Kikkert MJ; Noom MJ; Eeren HV; van Broekhuyzen AJ; Peen J; Luyten P; Busschbach JJ; Dekker JJ
    BMC Psychiatry; 2014 May; 14():149. PubMed ID: 24886402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial.
    Laurenssen EM; Smits ML; Bales DL; Feenstra DJ; Eeren HV; Noom MJ; Köster MA; Lucas Z; Timman R; Dekker JJ; Luyten P; Busschbach JJ; Verheul R
    BMC Psychiatry; 2014 Nov; 14():301. PubMed ID: 25403144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial.
    Beck E; Bo S; Gondan M; Poulsen S; Pedersen L; Pedersen J; Simonsen E
    Trials; 2016 Jul; 17(1):314. PubMed ID: 27405522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group schema-focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trial.
    van Dijk SDM; Veenstra MS; Bouman R; Peekel J; Veenstra DH; van Dalen PJ; van Asselt ADI; Boshuisen ML; van Alphen SPJ; van den Brink RHS; Oude Voshaar RC
    BMC Psychiatry; 2019 Jan; 19(1):26. PubMed ID: 30646879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a multicentered randomized controlled trial on the clinical and cost effectiveness of schema therapy for personality disorders.
    Bamelis LL; Evers SM; Arntz A
    BMC Public Health; 2012 Jan; 12():75. PubMed ID: 22272740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Group Schema Therapy for Outpatients with Severe Borderline Personality Disorder in Germany: A Pilot Study with Three Year Follow-Up.
    Fassbinder E; Schuetze M; Kranich A; Sipos V; Hohagen F; Shaw I; Farrell J; Arntz A; Schweiger U
    Front Psychol; 2016; 7():1851. PubMed ID: 27933020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.
    Crawford MJ; Sanatinia R; Barrett B; Byford S; Cunningham G; Gakhal K; Lawrence-Smith G; Leeson V; Lemonsky F; Lykomitrou G; Montgomery A; Morriss R; Paton C; Tan W; Tyrer P; Reilly JG
    Trials; 2015 Jul; 16():308. PubMed ID: 26187496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-FORCE: the effectiveness of group psychotherapy for Cluster-C personality disorders: protocol of a pragmatic RCT comparing psychodynamic and two forms of schema group therapy.
    van den Heuvel BB; Dekker JJM; Daniëls M; Van HL; Peen J; Bosmans J; Arntz A; Huibers MJH
    Trials; 2023 Apr; 24(1):300. PubMed ID: 37120550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: study protocol for a randomized controlled trial.
    Baljé A; Greeven A; van Giezen A; Korrelboom K; Arntz A; Spinhoven P
    Trials; 2016 Oct; 17(1):487. PubMed ID: 27717405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial.
    Farrell JM; Shaw IA; Webber MA
    J Behav Ther Exp Psychiatry; 2009 Jun; 40(2):317-28. PubMed ID: 19176222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of brief schema group therapy for borderline personality disorder symptoms: a randomized pilot study.
    Hilden HM; Rosenström T; Karila I; Elokorpi A; Torpo M; Arajärvi R; Isometsä E
    Nord J Psychiatry; 2021 Apr; 75(3):176-185. PubMed ID: 33103925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined group and individual schema therapy for borderline personality disorder: a pilot study.
    Dickhaut V; Arntz A
    J Behav Ther Exp Psychiatry; 2014 Jun; 45(2):242-51. PubMed ID: 24342235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schema therapy for borderline personality disorder: A qualitative study of patients' perceptions.
    Tan YM; Lee CW; Averbeck LE; Brand-de Wilde O; Farrell J; Fassbinder E; Jacob GA; Martius D; Wastiaux S; Zarbock G; Arntz A
    PLoS One; 2018; 13(11):e0206039. PubMed ID: 30462650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.